COMMUNIQUÉS West-GlobeNewswire

Onsite Health Diagnostics is the first to successfully complete CLIA-Waived Laboratory Regulatory Compliance Audit performed by eTrueNorth

29/03/2018 - 14:00

DALLAS, March 29, 2018 (GLOBE NEWSWIRE) -- e TrueNorth, the U.S. based healthcare technology & compliance solution provider for CLIA-waived laboratories, is the only provider that certifies regulatory compliance in [...]

Tyme Technologies, Inc. Announces Participation at the H.C. Wainwright Annual Global Life Sciences Conference in Monte Carlo, Monaco on April 8-10, 2018

29/03/2018 - 14:00

NEW YORK, March 29, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME ) (“Tyme” or the “Company”) announced today that it will be featured as a presenting company at the H. C. Wainwright Annual Global Life [...]

Jeff Arnold and Dr. Mehmet Oz to Join Governor Nathan Deal for Announcement about Improving Health of Georgia Residents

29/03/2018 - 13:35

ATLANTA, March 29, 2018 (GLOBE NEWSWIRE) -- Jeff Arnold and Dr. Mehmet Oz, co-founders of Sharecare, the digital health company helping people manage all their health in one place, will join Georgia Governor Nathan Deal [...]

New Published Clinical Trial Confirms NIAGEN® Supplementation Raised Nicotinamide Adenine Dinucleotide (NAD) Levels and Potentially Improves Blood Pressure and Cardiovascular Health

29/03/2018 - 13:30

IRVINE, Calif., March 29, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ: CDXC ), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today that results from a human [...]

Evolus Reports Fourth Quarter and Full Year 2017 Financial Results

29/03/2018 - 13:30

IRVINE, Calif., March 29, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS ) (“Evolus” or the “Company”), a medical aesthetics company focused on delivering advanced aesthetic procedures and treatments to physicians [...]

Auris Regains Compliance with Nasdaq's Minimum Bid Price Requirement

29/03/2018 - 13:01

Zug, Switzerland, March 29, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, today announced it [...]

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants

29/03/2018 - 12:30

FIT Biotech Oy Company release March 29, 2018 at 01:30 pm EET FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants On December 22, 2017, the Board of Directors of FIT Biotech Oy [...]

MediciNova Announces Results of Phase 2 Clinical Trial of MN-166 (ibudilast) in Methamphetamine Dependence

29/03/2018 - 12:30

LA JOLLA, Calif., March 29, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]

Ravenquest Completes Final Tranche of Non-brokered Financing

29/03/2018 - 12:00

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS VANCOUVER, British Columbia, March [...]

Amarin Sponsors Two Scientific Presentations Scheduled for National Kidney Foundation 2018 Spring Clinical Meetings

29/03/2018 - 11:00

BEDMINSTER, N.J. and DUBLIN, Ireland, March 29, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]

Esperite (ESP), The Cell Factory presents pre-clinical results on the new products of the 2nd generation EV's drugs for treatment of inflammatory diseases

29/03/2018 - 09:16

Esperite with its biotech company The Cell Factory has acquired from OPBG the full rights to the IP and the international patent family covering the invention and the therapeutic use of the EV's products. In [...]

Veritas Pharma Closes Private Placement

29/03/2018 - 09:10

VANCOUVER, British Columbia, March 29, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) ( “ Veritas ” or the “Company”) is pleased to announces the closing of a private placement of [...]

VALNEVA to Present on Lyme and Zika at the 18th World Vaccine Congress in Washington, D.C.

29/03/2018 - 08:31

Valneva to Present on Lyme and Zika at the 18 th World Vaccine Congress in Washington, D.C. Presentations to feature progress on Lyme and Zika vaccine candidates Lyon (France), March 29, 2018 - Valneva SE ("Valneva" or [...]

VALNEVA présentera sur Lyme et Zika au 18ème World Vaccine Congress de Washington, D.C.

29/03/2018 - 08:31

Valneva présentera sur Lyme et Zika au 18 ème World Vaccine Congress de Washington, D.C. Les présentations porteront sur les avancées cliniques des candidats vaccins contre la maladie de Lyme et le virus Zika Lyon ( [...]

Shire plc : Rule 2.9 Announcement

29/03/2018 - 08:01

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 29 March 2018 [...]

Saniona AB: Change in number of shares and votes in Saniona AB (publ)

29/03/2018 - 08:01

PRESS RELEASE March 29, 2018 During March, the registered number of shares and votes in Saniona AB (publ) ("Saniona") has increased due to conversion of convertible notes issued pursuant to the convertible notes funding [...]

Shire Reports Regulatory Milestones for Investigational Hereditary Angioedema (HAE) Treatment Lanadelumab

29/03/2018 - 08:01

Shire Reports Regulatory Milestones for Investigational Hereditary Angioedema (HAE) Treatment Lanadelumab The European Medicines Agency (EMA) validates Shire's Marketing Authorization Application for investigational [...]

Herantis Pharma publishes an introductory video on its drug candidate CDNF for the treatment of Parkinson's disease

29/03/2018 - 08:01

Herantis Pharma publishes an introductory video on its drug candidate CDNF for the treatment of Parkinson's disease Herantis Pharma Plc Press release 29 March 2018 at 9:00 am Herantis Pharma Plc ("Herantis") has [...]

Sanofi: EMA to review sotagliflozin as potential treatment for type 1 diabetes

29/03/2018 - 07:31

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) EMA to review sotagliflozin as potential treatment for type 1 diabetes Paris - March 29, 2018 - The European Medicines Agency (EMA) has accepted for review Sanofi [...]